ESCO Reports Second Quarter Fiscal 2024 Results
May 09, 2024 16:15 ET
|
ESCO Technologies Inc.
St. Louis, May 09, 2024 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the second quarter ended March 31, 2024 (Q2 2024). ...
Bunzl Canada Builds Sustainability Culture with “For Better” Initiative
May 09, 2024 09:04 ET
|
Bunzl Canada Inc
BURLINGTON, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- Bunzl Canada today announced the results of the inaugural Bunzl for Better branded sustainability campaign, held throughout the month of...
Flourish RIA Fintech Hits $5 Billion AUC Milestone
May 09, 2024 09:00 ET
|
Flourish
New York, May 09, 2024 (GLOBE NEWSWIRE) -- Flourish, a platform that provides innovative access to financial products that help registered investment advisors (“RIAs”) improve their clients’...
Stifel to Sponsor the Tewaaraton Award, Honoring the Nation’s Top College Lacrosse Players
May 09, 2024 09:00 ET
|
Stifel Financial Corporation
ST. LOUIS, May 09, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that it has entered into a multiyear agreement to serve as presenting sponsor of The Tewaaraton Award,...
Advantage Solutions Reports First Quarter Results with New Reporting Segments and Reaffirms its 2024 Outlook
May 09, 2024 07:00 ET
|
Advantage Solutions, Inc.
Management reaffirms its 2024 outlook as first-quarter results met expectations despite soft market conditions and higher-than-expected costs and investments.Inclusive of discontinued operations,...
Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend
May 08, 2024 17:00 ET
|
Stifel Financial Corporation
ST. LOUIS, May 08, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.42 per...
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
May 08, 2024 16:15 ET
|
Merus N.V.
Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data at 2024 ASCO Annual Meeting; preparing for a potential phase 3 trialZeno BLA accepted for priority review by...
TierPoint Completes New $550 Million Securitization Financing
May 08, 2024 09:00 ET
|
TierPoint
ST. LOUIS, May 08, 2024 (GLOBE NEWSWIRE) -- TierPoint, a leading, national enterprise data center company and provider of secure, connected IT platform solutions that power digital transformation...
Bunzl For Better: Canada’s New National Sustainability Initiative
May 08, 2024 06:00 ET
|
Bunzl Canada Inc
BURLINGTON, Ontario, May 08, 2024 (GLOBE NEWSWIRE) -- Bunzl Canada today announced the results of the inaugural Bunzl for Better sustainability campaign held in conjunction with April’s Earth...
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 07, 2024 16:01 ET
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update